Norepinephrine Bitartrate (BayCare) – Subpotent Drug (2022)
Class III: A situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences
Class III recall indicates unlikely adverse health consequences.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Norepinephrine bitartrate 16 mg in 250 mL NaCl 0.9%, packaged in IV bags, Rx only, BayCare Central Pharmacy 7802 E. Telecom Parkway Temple Terrace, FL 33637 (813) 901-6392
Brand
BayCare Integrated Service Center, LLC /dba BayCare Central Pharmacy
Lot Codes / Batch Numbers
Lot #: Nore1620220111, Nore1620220113, Nore1620220118, Nore1620220125, Nore1620220127, Nore1620220202, Exp 3/31/22
Products Sold
Lot #: Nore1620220111, Nore1620220113, Nore1620220118, Nore1620220125, Nore1620220127, Nore1620220202, Exp 3/31/22
BayCare Integrated Service Center, LLC /dba BayCare Central Pharmacy is recalling Norepinephrine bitartrate 16 mg in 250 mL NaCl 0.9%, packaged in IV bags, Rx only, BayCare Central P due to Subpotent drug. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA drug enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Subpotent drug
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm, their healthcare provider, or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticeDistribution
As reported by FDA
FL
Page updated: Jan 7, 2026